Authors’ Reply to Godman and Gustafsson: “A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing”
Extent: | text/html |
---|
Type of publication: | Article
|
---|
Source: | |
Persistent link: https://www.econbiz.de/10011000861